NICHOLAS INVESTMENT PARTNERS, LP Horizon Therapeutics Public Limited Company Transaction History

NICHOLAS INVESTMENT PARTNERS, LP portfolio value:

$15.04M
portfolio value

NICHOLAS INVESTMENT PARTNERS, LP quarter portfolio value change:

-22.40%
quarter

Horizon Therapeutics Public Limited Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +13.46% 28.84K shares -2.04M $61.89 243.12K
Q2 2022 share Decrease -10.69% -25.64K shares -8.15M $79.76 214.27K
Q1 2022 share Increase +48.96% 78.86K shares 7.88M $105.21 239.92K
Q4 2021 share Increase +8.65% 12.81K shares 1.11M $108.26 161.06K
Q3 2021 share Decrease -34.93% -79.59K shares -5.09M $109.54 148.24K
Q2 2021 share Decrease -15.81% -42.79K shares -3.57M $93.64 227.83K
Q1 2021 share Decrease -5.06% -14.41K shares 4.05M $92.04 270.63K
Q4 2020 share Increase +7.83% 20.69K shares 316K $73.15 285.04K
Q3 2020 share Increase +414.52% 212.97K shares 17.67M $77.68 264.35K
Q2 2020 share Decrease -68.22% -110.28K shares -1.93M $55.58 51.37K
Q1 2020 share Decrease -16.86% -32.77K shares -2.25M $29.62 161.66K
Q4 2019 share Decrease -46.60% -169.67K shares -2.87M $36.2 194.43K
Q3 2019 share Increase +72.42% 152.93K shares 4.83M $27.23 364.11K
Q2 2019 share Increase 0.00% 211.17K shares 5.08M $24.06 211.17K